Skip to main content

Transient Ischemic Attack

3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Boston Scientific
Boston ScientificCA - Valencia
1 program
1
EndoTex™ NexStent™Phase 31 trial
Active Trials
NCT00600327Completed488Est. Jun 2007
Orion Pharma
Orion PharmaUK - Reading
1 program
1
LevosimendanPhase 21 trial
Active Trials
NCT00698763Completed32Est. Sep 2009
Orion
OrionUK - Cambridge
1 program
1
LevosimendanPhase 2
ResMed
ResMedSAN DIEGO, CA
1 program
auto-titrating continuous positive airway pressurePHASE_21 trial
Active Trials
NCT00251290Completed62Est. Sep 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Boston ScientificEndoTex™ NexStent™
Orion PharmaLevosimendan
ResMedauto-titrating continuous positive airway pressure

Clinical Trials (3)

Total enrollment: 582 patients across 3 trials

NCT00600327Boston ScientificEndoTex™ NexStent™

Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™

Start: Dec 2001Est. completion: Jun 2007488 patients
Phase 3Completed
NCT00698763Orion PharmaLevosimendan

Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables

Start: Aug 2008Est. completion: Sep 200932 patients
Phase 2Completed
NCT00251290ResMedauto-titrating continuous positive airway pressure

Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack

Start: Nov 2004Est. completion: Sep 200762 patients
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.